310 related articles for article (PubMed ID: 1474274)
21. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
22. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.
Bechelli LM; Lwin K; Gallego Garbajosa P; Mg-Mg-Gyi ; Uemura K; Sundaresan T; Tamondong C; Matejka M; Sansarricq H; Walter J
Bull World Health Organ; 1974; 51(1):93-9. PubMed ID: 4281729
[TBL] [Abstract][Full Text] [Related]
23. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
Velema JP; Ogbeiwi OI
Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
[TBL] [Abstract][Full Text] [Related]
24. BCG vaccination. Comparative study of the lepromin response (Mitsuda-test) to the oral and intradermal routes of administration of the vaccine.
Azulay RD; Kahn H; Scorzelli A; Meyerheim R
Int J Lepr Other Mycobact Dis; 1971; 39(2):508-21. PubMed ID: 5169811
[No Abstract] [Full Text] [Related]
25. Protective role of BCG vaccination against tuberculous meningitis in Indian children: a reappraisal.
Kumar P; Kumar R; Srivastava KL; Kumar M
Natl Med J India; 2005; 18(1):7-11. PubMed ID: 15835483
[TBL] [Abstract][Full Text] [Related]
26. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
[TBL] [Abstract][Full Text] [Related]
27. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of bacillus Calmette Guerin (BCG) vaccination against extra-pulmonary tuberculosis: a case-control study.
Zodpey SP; Maldhure BR; Dehankar AG; Shrikhande SN
J Commun Dis; 1996 Jun; 28(2):77-84. PubMed ID: 8810141
[TBL] [Abstract][Full Text] [Related]
29. Spatial patterns of leprosy in an urban area of central Brazil.
Martelli CM; Moraes Neto OL; Andrade AL; Silva SA; Silva IM; Zicker F
Bull World Health Organ; 1995; 73(3):315-9. PubMed ID: 7614663
[TBL] [Abstract][Full Text] [Related]
30. Long-term effect of leprosy control in two Prefectures of China, 1955-1993.
Li HY; Weng XM; Li T; Zheng DY; Mao ZM; Ran SP; Liu FW
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):213-21. PubMed ID: 7602216
[TBL] [Abstract][Full Text] [Related]
31. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
Vallishayee RS; Anantharaman DS; Gupte MD
Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
[TBL] [Abstract][Full Text] [Related]
32. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
[TBL] [Abstract][Full Text] [Related]
33. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
[TBL] [Abstract][Full Text] [Related]
34. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.
Nackers F; Dramaix M; Johnson RC; Zinsou C; Robert A; DE Biurrun Bakedano E; Glynn JR; Portaels F; Tonglet R
Am J Trop Med Hyg; 2006 Oct; 75(4):768-74. PubMed ID: 17038709
[TBL] [Abstract][Full Text] [Related]
35. Vaccination and skin test studies on the children of leprosy patients.
Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of bacillus of Calmette-Guerin (BCG) vaccination against tuberculous meningitis: a case-control study.
Zodpey SP; Maldhure BR; Shrikhande SN; Tiwari RR
J Indian Med Assoc; 1996 Sep; 94(9):338-40. PubMed ID: 9019079
[TBL] [Abstract][Full Text] [Related]
37. Skin test studies on close contacts of leprosy patients in India.
Lord R; Naish C; Taylor C; Stanford CA; Stanford CJ; Chacko JG; Debanbu V; Samson PD; Berchmans J; Surendran D
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):801-9. PubMed ID: 2809346
[TBL] [Abstract][Full Text] [Related]
38. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
39. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of BCG against leprosy in South Sulawesi, Indonesia.
Boelens JJ; Kroes R; van Beers S; Lever P
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):456-7. PubMed ID: 7594932
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
